Table 1.
Patient characteristics with focal uptake in the thyroid where a final diagnosis was available
| No. | Age, years | Sex | Primary | SUVmax | Final diagnosis | Modality for final diagnosis |
|---|---|---|---|---|---|---|
| 1 | 67 | F | Breast | 7 | Benign nodule | FNAC |
| 2 | 68 | F | Breast | 3.4 | Benign nodule | USG |
| 3 | 52 | F | Colorectal | 1.7 | Benign nodule | FNAC |
| 4 | 75 | M | Colorectal | 3.8 | Benign nodule | FNAC |
| 5 | 72 | F | CUPS | 14.5 | Benign nodule | FNAC |
| 6 | 68 | F | CUPS | 2.4 | Benign nodule | FNAC |
| 7 | 46 | F | Lymphoma (HL) | 1.6 | Benign nodule | FNAC |
| 8 | 59 | F | Lung | 7.5 | Benign nodule | FNAC |
| 9 | 64 | F | Lung | 5.8 | Benign nodule | FNAC |
| 10 | 84 | M | Lung | 2.9 | Benign nodule | USG |
| 11 | 58 | F | Lung | 5.6 | Benign nodule | FNAC |
| 12 | 65 | M | Lung | 7.8 | Benign nodule | FNAC |
| 13 | 73 | F | Lung | 5.9 | Benign nodule | Histopathology |
| 14 | 68 | F | Lung | 5.4 | Benign nodule | Histopathology |
| 15 | 76 | F | Melanoma | 6.7 | Benign nodule | USG |
| 16 | 91 | F | Melanoma | 3.9 | Benign nodule | USG |
| 17 | 46 | F | Lymphoma (NHL) | 4.9 | Benign nodule | FNAC |
| 18 | 72 | F | Lymphoma (NHL) | 2.5 | Benign nodule | FNAC |
| 19 | 43 | F | Lymphoma (NHL) | 3.4 | Benign nodule | FNAC |
| 20 | 84 | M | Lymphoma (NHL) | 39.0 | Benign nodule | FNAC |
| 21 | 43 | F | Lymphoma (NHL) | 4.5 | Benign nodule | FNAC |
| 22 | 79 | M | Lymphoma (NHL) | 4.5 | Benign nodule | FNAC |
| 23 | 35 | F | Lymphoma (NHL) | 5.0 | Benign nodule | FNAC |
| 24 | 82 | F | Lymphoma (NHL) | 9.9 | Benign nodule | USG |
| 25 | 53 | F | Lymphoma (NHL) | 2.1 | Benign nodule | Histopathology |
| 26 | 51 | F | Lymphoma (NHL) | 10.3 | Benign nodule | FNAC |
| 27 | 71 | F | Lymphoma (NHL) | 2.5 | Benign nodule | FNAC |
| 28 | 66 | M | Lymphoma (NHL) | 5 | Benign nodule | Histopathology |
| 29 | 61 | M | Oesophagus | 9.1 | Benign nodule | FNAC |
| 30 | 48 | F | Oesophagus | 20.5 | Benign nodule | FNAC |
| 31 | 81 | F | SqCC (anterior abdominal wall) | 15 | Benign nodule | FNAC |
| 32 | 58 | M | SqCC HN | 15 | Benign nodule | FNAC |
| 33 | 77 | F | Small fibre neuropathy | 5.5 | Benign nodule | FNAC |
| 34 | 75 | F | Stomach | 4.5 | Benign nodule | USG |
| 35 | 47 | M | Thymus | 4.5 | Benign nodule | FNAC |
| 36 | 81 | M | Colorectal | 15 | Metastases | Histopathology |
| 37 | 65 | M | SqCC HN | 9.2 | Metastases | FNAC |
| 38 | 65 | F | Lung | 10.7 | Metastases | FNAC |
| 39 | 84 | M | Lymphoma (NHL), lung | 11.5 | NHL | FNAC |
| 40 | 66 | F | Lung | 15.2 | PTC | Histopathology |
| 41 | 58 | M | SPN characterisation | 17.4 | PTC | Histopathology |
| 42 | 46 | M | Lymphoma – Sézary syndome | 15.2 | PTC | Histopathology |
| 43 | 48 | F | Lymphoma (NHL) | 29.4 | PTC | Histopathology |
| 44 | 49 | F | SqCC HN | 17.8 | PTC | Histopathology |
| 45 | 65 | F | Lung | 3.8 | THY3 | FNAC |
| 46 | 49 | M | Thymoma | 8.3 | THY3 | FNAC |
| 47 | 37 | F | Melanoma | 2.1 | Thyroiditis | FNAC |
CUPS = Carcinoma of unknown primary site; NHL = non-Hodgkins lymphoma; HL = Hodgkins lymphoma; SqCC = squamous cell carcinoma; HN = head and neck; SPN = solitary pulmonary nodule; THY3 = follicular lesion/follicular neoplasm.